Company · CIK 1733257
Finch Therapeutics Group, Inc.
| CIK | 1733257 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2836 — Biological Products, (No Diagnostic Substances) |
| Incorporated in | DE |
| Business address | MA |
| Listed | no ticker on SEC record today |
| First annual or quarterly report | 2021-05-13 |
Offerings
2 registrations| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-265173 | 2022-05-24 | 2024-11-04 | 3 | |
| 333-253622 | 2021-02-26 | 2021-03-22 | 5 |
Filings
9| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2024-11-04 | EFFECTDeclared effective | 333-265173 | 9999999995-24-003352 |
| 2022-06-02 | EFFECTDeclared effective | 333-265173 | 9999999995-22-001677 |
| 2022-05-24 | S-3Shelf registered | 333-265173 | 0001193125-22-158515 |
| 2021-03-22 | 424B4Final prospectus | 333-253622 | 0001193125-21-089746 |
| 2021-03-18 | EFFECTDeclared effective | 333-253622 | 9999999995-21-001005 |
| 2021-03-18 | S-1/AAmendment | 333-253622 | 0001193125-21-084824 |
| 2021-03-15 | S-1/AAmendment | 333-253622 | 0001193125-21-080450 |
| 2021-02-26 | S-1Registration filed | 333-253622 | 0001193125-21-060632 |
| 2020-12-28 | DRSDraft made public | 377-03954 | 0000950123-20-012897 |